Navigating the complex intersection of healthcare policy and the financial viability of medical innovation requires a deep understanding of how federal regulations dictate the flow of capital. We are speaking today with an expert who has spent years at the forefront of medical technology and the manufacturing of diagnostic tools, witnessing firsthand how reimbursement disputes can either stall or stimulate clinical progress. This conversation explores a landmark ruling by the Fifth Circuit Court of Appeals that has sent shockwaves through the industry by dismantling the current methodology used to calculate out-of-network payments under the No Surprises Act. We examine the elimination of “ghost rates,” the inclusion of provider incentives in payment formulas, and what this shifting legal landscape means for the future of healthcare providers and the technology they rely on to treat patients.
The Qualifying Payment Amount currently serves as the primary benchmark for settling out-of-network claims. How does the recent ruling by the Fifth Circuit change the gravity of this figure for healthcare providers?
The Qualifying Payment Amount, or QPA, has been the “north star” for arbitration since the No Surprises Act took effect in 2022, but for many providers, it felt like a star that was intentionally dimmed by payers. This ruling is a monumental victory because it acknowledges that the math used by insurance regulators was fundamentally skewed to lowball physicians. By striking down parts of the current methodology, the court is essentially saying that the anchor used in negotiations must reflect the true economic reality of medical care. For providers who have felt squeezed by artificially low median rates, this represents a massive shift toward a more equitable playing field where the “median” actually reflects fair compensation.
The Texas Medical Association raised concerns about “ghost rates” influencing these calculations. Can you explain the mechanics of how these rates were dragging down the benchmark and why the court found them problematic?
Ghost rates are essentially phantom numbers—contracted rates for services that a provider never actually intended to deliver or was not even equipped to perform in their specific geographic area. Payers were folding these irrelevant, often very low, figures into the median calculation, which naturally dragged the entire benchmark down into the basement. It is a classic case of gaming the system, and the court saw right through the strategy, ruling that these rates have no business being in the formula. When you remove these artificial depressants, the QPA should naturally rise, which means future arbitration outcomes will finally start to look more like fair market compensation rather than a race to the bottom.
Beyond the removal of ghost rates, the court also addressed the exclusion of bonus and incentive payments. What is the significance of integrating these variables into the new formula?
Bonus and incentive payments are not just “extra” money; they represent a significant share of a provider’s contracted compensation in today’s modern healthcare environment. By excluding them, regulators were effectively ignoring a huge chunk of the actual money that changes hands between payers and providers for high-quality care. The court’s decision to mandate their inclusion ensures that the QPA reflects the full scope of what an insurance company actually pays for a service. This change is expected to push payouts higher across the board because it forces the formula to recognize the total financial value of the work performed, not just the bare-bones base rate.
While providers won on several fronts, the court did side with the government regarding one-off contracts, such as those for air ambulance services. How does this limitation impact the overall reach of the ruling?
It is important to note that the Texas Medical Association did not get every single item on its wish list, and the exclusion of one-off contracts remains a notable hurdle. Air ambulance services and other unique, non-recurring contracts will still be left out of the rate pool used to calculate the QPA, leaving those specific sectors in a more vulnerable position. However, even with this limitation, the ruling is the association’s fourth successful legal challenge since 2022, which shows a consistent pattern of chipping away at a formula that many felt was rigged from the start. It proves that while the government can exclude some data, it cannot ignore the fundamental principles of fair math when it comes to the bulk of medical services.
Since the existing formula remains in place until a replacement is crafted, what should providers and payers expect during this transitional period?
Right now, everyone is in a high-stakes “wait and see” mode because there is no set deadline for when the Departments of Health and Human Services, Labor, and Treasury must deliver the new methodology. This creates a strange, lingering period of uncertainty where the old, flawed rules still technically apply while the replacement is being drafted in the shadows. Providers are watching the clock, hoping for a swift and aggressive rework of the formula that preserves their practice viability and patient access. Meanwhile, payers are likely bracing for a future where they can no longer lean on the tactics that have defined the arbitration process over the last two years.
What is your forecast for the future of the No Surprises Act implementation?
I expect the implementation of the No Surprises Act to remain in a state of near-constant litigation for the foreseeable future as both sides fight for every inch of financial ground. This latest ruling is a step toward a more transparent and lawful system, but the actual “new” formula will likely trigger its own set of challenges once it is finally released to the public. We are moving toward a landscape where the arbitration process will become more expensive for payers as QPAs rise, which may eventually force more good-faith contracting rather than relying on out-of-network disputes. Ultimately, the goal is to protect patients from surprise bills while ensuring physicians are not driven out of business by a methodology that ignores the real costs of providing life-saving care.
